Flaming Lips Reveal Guests For World-Record Road Trip

During O Music Awards, 'Jackass' star Chris Pontius, Neon Trees and Jackson Browne will join the Lips as they try to land Guinness spot.
By Brendan Dempsey

Wayne Coyne of Flaming Lips
Photo:

It's no secret that the Flaming Lips have their sights set on the Guinness World Record for most concerts performed in multiple cities in a 24-hour time period. The innovative rockers have just announced they will be joined by "Jackass" and "Wildboyz" star Chris Pontius, Jackson Browne, Neon Trees, Karmin and a slew of additional artists as they gun for the record, currently held by Jay-Z, who played seven shows from Atlanta to L.A. in 2006.

The Flaming Lips and friends plan to play eight shows from Memphis, Tennessee, to New Orleans, beginning Wednesday at 7:30 p.m. ET and continuing for 24 hours. The gigs will take place in conjunction with the O Music Awards, a 24-hour awards ceremony that will be broadcast on MTV, VH1 and CMT and livestream at Omusicawards.com. The Flaming Lips will jump aboard their aptly named bus, "Endeavor," and travel to each new location just as the opening band is finishing its set. They'll perform what promises to be a raucous and exciting mini-set before moving on to the next location.

The O Music Awards ceremony will give out 24 awards, one for each hour of the festival. Categories that artists are vying to win include Must Follow Artist on Twitter, Best Online Concert Experience, Most Adorable Viral Star, Fan Army FTW, Best Music App and Digital Genius Award.

"The O Music Awards are all about the celebrating the wonderfully messy and soulful spirit of music," said Van Toffler, President of Viacom's Music and Logo Group. "This insane bus brigade and the assorted collection of artists and pranksters that are taking part not only make me incredibly happy, but pretty much sum up what a good 24 hour binge should involve, minus the libations."

Along with the pomp and circumstance of winning awards, the first 12 installments of Stop/Watch will air during the concerts. Stop/Watch is a 60-second online music series in which artists have one minute flat to perform a complete song — with a countdown clock running! The first 12 Stop/Watch artists are: Joseph Arthur, Carolina Chocolate Drops, Citizen's Band, John Forte, the Hives, Rhett Miller, Miracles of Modern Science, Peasant, Punch Brothers, Saint Motel, P.T. Walkley and the Wombats.

Tickets to all of the O Music Awards shows can be purchased here. You can also catch the show live on your smart phone through the mobile web or the MTV News app.

Here's the full lineup of shows:

» 6/27 - New Fumes, the Flaming Lips: Memphis, TN @ Handy Park
» 6/27 - Gary Clark Jr., the Flaming Lips: Clarksdale, MS @ Ground Zero Blues' Club
» 6/27 - Grace Potter & the Nocturnals, the Flaming Lips: Oxford, MS @ The Lyric
» 6/28 - Neon Indian, the Flaming Lips: Jackson, MS @ Duling Hall
» 6/28 - Hunter Hayes, the Flaming Lips: Hattiesburg, MS @ Benny's Boom Boom Room
» 6/28 - Neon Trees, the Flaming Lips: Biloxi, MS @ Hard Rock Casino
» 6/28 - Givers, the Flaming Lips: Baton Rouge, LA @ Varsity
» 6/28 - Grimes, the Flaming Lips: New Orleans, LA @ House of Blues

Related Artists

• The Flaming Lips

paris jackson paris jackson howard stern americas got talent china aircraft carrier barbara walters most fascinating person 2011 golden globe nominations los angeles clippers

7 pharmaceutical companies join academic researchers to speed TB drug discovery

Public release date: 25-Jun-2012
[ | E-mail | Share ]

Contact: Daniel Pawson
dpawson@globalhealthstrategies.com
718-873-3169
Global Health Strategies

Groundbreaking partnership seeks rapid cure to reduce treatment time from 6 months to 1 month

Seven pharmaceutical companies and four research institutions, working with the Bill & Melinda Gates Foundation, have launched a groundbreaking partnership that aims to speed the discovery of essential new treatments for tuberculosis (TB).

The partnership, known as the TB Drug Accelerator (TBDA), will target the discovery of new TB drugs by collaborating on early-stage research. The long-term goal of the TBDA is to create a TB drug regimen that cures patients in only one month. Existing drugs, all at least 50 years old, require six months to cure the disease a lengthy process that contributes to 20-30% of patients dropping out before completion.

Aided by nearly $20 million from the Gates Foundation, partners officially launched the TBDA in April and have begun the first round of screening for new TB drug candidates. The TBDA aims to develop five new preclinical drug candidates with treatment-shortening potential within 5 years and proof-of-concept for a one-month three-drug regimen within 10 years.

"The TB Drug Accelerator establishes a new paradigm of cooperation in drug discovery," said Sanofi Chief Executive Officer Chris Viehbacher, speaking on behalf of the pharmaceutical industry partners. "By working together on this, we can optimize our research and speed the development of one of the most pressing needs in global health."

Through this partnership, the participating pharmaceutical companies -- Abbott, AstraZeneca, Bayer, Eli Lilly, GlaxoSmithKline, Merck and Sanofi will open up targeted sections of their compound libraries and share data with each other and four research institutions: the Infectious Disease Research Institute; the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health; Texas A&M University; and Weill Cornell Medical College. Breaking from traditional research and development practices, the companies will work together to develop the best prospects, regardless of where the drug originated. The structures of lead compounds identified through the program will ultimately be placed in the public domain.

"TB drug discovery has reached a crossroads," said Dr. Carl Nathan, Professor and Chairman of the Department of Microbiology and Immunology at Weill Cornell Medical College. "Finding new and faster-acting TB drugs will take a new kind of partnership, connecting not only academia and industry, but drug company with drug company. The TB Drug Accelerator is a historic experiment in innovative collaboration."

Tuberculosis is a bacterial infection that attacks the respiratory system and other organs. It is the second leading infectious cause of death worldwide, having killed nearly 1.4 million people in 2010 alone. At any given moment, more than 12 million people around the world are suffering from active TB.

The high percentage of patients who fail to complete the current six-month treatment regimen adds significantly to the TB burden. High default rates lead to increased mortality, contribute to TB drug resistance and allow patients to continue to infect others. Shortening treatment regimens to even two months would keep an additional one million people on treatment each year.

"Innovative partnerships are critical to helping us solve the most pressing challenges of global health," said Trevor Mundel, president of the Global Health Program at the Bill & Melinda Gates Foundation. "It's our hope that the TB Drug Accelerator will set a precedent for drug discovery and serve as a resource for others."

The TBDA will add to existing collaborative efforts on TB, building a more robust drug discovery pipeline to complement other initiatives, such as Critical Pathways to TB Drug Regimens (CPTR), which works with the Global Alliance for TB Drug Development to speed the clinical development of new combination TB drug therapies.

###

Media contacts for partners follow:

• Abbott: Colin McBean, +1 847 938 3083, colin.mcbean@abbott.com
• AstraZeneca: Andrea Conners, +1 610 620 5675, andrea.conners@astrazeneca.com
• Bayer HealthCare AG: Kerstin Crusius, +49 (0)30 468 14726, kerstin.crusius@bayer.com
• Bill & Melinda Gates Foundation: +1 206 709 3400, media@gatesfoundation.org
• Eli Lilly: David Marbaugh, +1 317 277 5620, marbaugh_david_j@lilly.com
• GlaxoSmithKline: David Daley, +44 (0)20 8047 2615, david.t.daley@gsk.com
• Infectious Disease Research Institute: Tanya Parish, +1 206 330 2525, tanya.parish@idri.org
• Merck & Co.: Kelley Dougherty, +1 908 423 4291, kelley.dougherty@merck.com
• National Institute of Allergy and Infectious Diseases: Kathy Stover, +1 301 451 2278, kathy.stover@nih.gov
• Sanofi: Jean-Marc Podvin, +33 (0) 6 7457 5170, jean-marc.podvin@sanofi.com
• Texas A&M University: Tom Hughes, +1 979 862 4001, tomhughes@tamu.edu
• Weill Cornell Medical College: Lauren Woods, +1 212 821 0579, law2014@med.cornell.edu

---

[ | E-mail | Share ]

?

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

Public release date: 25-Jun-2012
[ | E-mail | Share ]

Contact: Daniel Pawson
dpawson@globalhealthstrategies.com
718-873-3169
Global Health Strategies

Groundbreaking partnership seeks rapid cure to reduce treatment time from 6 months to 1 month

Seven pharmaceutical companies and four research institutions, working with the Bill & Melinda Gates Foundation, have launched a groundbreaking partnership that aims to speed the discovery of essential new treatments for tuberculosis (TB).

The partnership, known as the TB Drug Accelerator (TBDA), will target the discovery of new TB drugs by collaborating on early-stage research. The long-term goal of the TBDA is to create a TB drug regimen that cures patients in only one month. Existing drugs, all at least 50 years old, require six months to cure the disease a lengthy process that contributes to 20-30% of patients dropping out before completion.

Aided by nearly $20 million from the Gates Foundation, partners officially launched the TBDA in April and have begun the first round of screening for new TB drug candidates. The TBDA aims to develop five new preclinical drug candidates with treatment-shortening potential within 5 years and proof-of-concept for a one-month three-drug regimen within 10 years.

"The TB Drug Accelerator establishes a new paradigm of cooperation in drug discovery," said Sanofi Chief Executive Officer Chris Viehbacher, speaking on behalf of the pharmaceutical industry partners. "By working together on this, we can optimize our research and speed the development of one of the most pressing needs in global health."

Through this partnership, the participating pharmaceutical companies -- Abbott, AstraZeneca, Bayer, Eli Lilly, GlaxoSmithKline, Merck and Sanofi will open up targeted sections of their compound libraries and share data with each other and four research institutions: the Infectious Disease Research Institute; the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health; Texas A&M University; and Weill Cornell Medical College. Breaking from traditional research and development practices, the companies will work together to develop the best prospects, regardless of where the drug originated. The structures of lead compounds identified through the program will ultimately be placed in the public domain.

"TB drug discovery has reached a crossroads," said Dr. Carl Nathan, Professor and Chairman of the Department of Microbiology and Immunology at Weill Cornell Medical College. "Finding new and faster-acting TB drugs will take a new kind of partnership, connecting not only academia and industry, but drug company with drug company. The TB Drug Accelerator is a historic experiment in innovative collaboration."

Tuberculosis is a bacterial infection that attacks the respiratory system and other organs. It is the second leading infectious cause of death worldwide, having killed nearly 1.4 million people in 2010 alone. At any given moment, more than 12 million people around the world are suffering from active TB.

The high percentage of patients who fail to complete the current six-month treatment regimen adds significantly to the TB burden. High default rates lead to increased mortality, contribute to TB drug resistance and allow patients to continue to infect others. Shortening treatment regimens to even two months would keep an additional one million people on treatment each year.

"Innovative partnerships are critical to helping us solve the most pressing challenges of global health," said Trevor Mundel, president of the Global Health Program at the Bill & Melinda Gates Foundation. "It's our hope that the TB Drug Accelerator will set a precedent for drug discovery and serve as a resource for others."

The TBDA will add to existing collaborative efforts on TB, building a more robust drug discovery pipeline to complement other initiatives, such as Critical Pathways to TB Drug Regimens (CPTR), which works with the Global Alliance for TB Drug Development to speed the clinical development of new combination TB drug therapies.

###

Media contacts for partners follow:

• Abbott: Colin McBean, +1 847 938 3083, colin.mcbean@abbott.com
• AstraZeneca: Andrea Conners, +1 610 620 5675, andrea.conners@astrazeneca.com
• Bayer HealthCare AG: Kerstin Crusius, +49 (0)30 468 14726, kerstin.crusius@bayer.com
• Bill & Melinda Gates Foundation: +1 206 709 3400, media@gatesfoundation.org
• Eli Lilly: David Marbaugh, +1 317 277 5620, marbaugh_david_j@lilly.com
• GlaxoSmithKline: David Daley, +44 (0)20 8047 2615, david.t.daley@gsk.com
• Infectious Disease Research Institute: Tanya Parish, +1 206 330 2525, tanya.parish@idri.org
• Merck & Co.: Kelley Dougherty, +1 908 423 4291, kelley.dougherty@merck.com
• National Institute of Allergy and Infectious Diseases: Kathy Stover, +1 301 451 2278, kathy.stover@nih.gov
• Sanofi: Jean-Marc Podvin, +33 (0) 6 7457 5170, jean-marc.podvin@sanofi.com
• Texas A&M University: Tom Hughes, +1 979 862 4001, tomhughes@tamu.edu
• Weill Cornell Medical College: Lauren Woods, +1 212 821 0579, law2014@med.cornell.edu

---

[ | E-mail | Share ]

?

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

il postino il postino online black friday deals college football scores maggie daley black friday online deals black friday news

Automotive News, Auto News and Trends from Automotive Digest ...

Ron Cogan Launches Auto Enthusiast Website with Unique Perspectives

Ron Cogan, the well-known edi?tor and pub?lisher of Green Car Jour?nal, has launched Car?sOfChange ?, an all-new auto enthu?si?ast web?site cov?er?ing ?the most impor?tant top?ics of the day like fuel effi?ciency and reduc?ing oil depen?dence, while empha?siz?ing the joy of dri?ving and car own?er?ship,? Cogan says. The pub?li?ca?tion pro?files trends, devel?op?ments, and road tests by sea?soned auto writ?ers who under?stand the evolv?ing inter?sec?tion of auto?mo?biles, energy, and the envi?ron?ment ? along with the con?ver?gence of sophis?ti?cated elec?tron?ics in cars. The web?site is unique among major auto enthu?si?ast pub?li?ca?tions because it show?cases the per?spec?tive of the nation?s most high-profile envi?ron?men?tal orga?ni?za?tions, sci?ence and effi?ciency experts, and auto indus?try exec?u?tives. The Sierra Club, Nat?ural Resources Defense Coun?cil, Amer?i?can Coun?cil for an Energy Effi?cient Econ?omy, Argonne National Lab?o?ra?tory, Global Green USA, SoCal Gas, 3M, and the Union of Con?cerned Sci?en?tists are shar?ing perspectives.

If you visit the web?site, you can read arti?cles on elec?tron?ics and edu?ca?tion on effi?cient dri?ving, the lat?est devel?op?ments on nat?ural gas trans?porta?tion, and Fisker Auto?mo?tive CEO Hen?rik Fisker talk?ing about the lat?est on its Karma plug-in hybrid and the birth of a brand. ?Cars of Change will get gear?heads talk?ing about the future of vehi?cles from the tech?no?log?i?cal, envi?ron?men?tal, and enthu?si?ast per?spec?tives ? all in the same place,? says Therese Langer, Trans?porta?tion Pro?gram Direc?tor of the Amer?i?can Coun?cil for an Energy Effi?cient Econ?omy (ACEEE).

?

its a wonderful life rex ryan yule log ham recipes adrian peterson darlene love free kindle books

Several Ideas On Online Marketing | Internet Marketing Strategies

Promoting your online business on the web is essential in today?s globe. The business owner who ignores this particular gold my own of possible opportunity will so at his / her own danger. There is an excessive amount of to end up being gained through making money online, and little to become lost. If a person company is online to start with, this is really a no-brainer, of program. But points are quickly changing on the internet, and individuals marketing methods that worked a couple of years ago might not work too today. Here really are a few steps you can take to expose your company to potential new clients that function today, but might not in a couple of years.

SEO. Search motor optimization. For the web entrepreneur who desires their website to become a success, this is the initial step toward making certain success. Unless you?ve unlimited money with which to market your item, this is really a step you can?t afford in order to skip. Optimizing your site is the same as building your own brick-and-mortar store inside a major buying district instead of halfway lower a grime road by having an old rustic sign pointing within the other path. Its importance can?t be overstated. There tend to be many aspects to SEARCH ENGINE OPTIMIZATION, and insufficient room in the following paragraphs to enter them. Fortunately, few topics happen to be as exhaustively discussed. Do the Google search of your, and you will discover plenty to see.

Pay For each Click. This is actually another fine method to get your online business away and operating. This service emerges by Search engines, Yahoo!, and WINDOWS LIVE MESSENGER, to name several. With Search engines AdWords, you?re going to achieve the most possible traffic, but you may even have probably the most competition for top keywords. What will this imply? Well, AdWords (and also the others) function by allowing you to create a good advertisement (generally a heading and a few sentences). You after that must pick the keywords which will activate your own ad. Then a person place the bid how much you?re prepared to ppc of your own ad, depending upon each key phrase. It just about all sounds much more confusing than it?s. The advantage of this kind of advertising (instead of, say, banner marketing), is you simply pay if you have been ensured of the visitor. Of program, what you need to do with which visitor is your decision and your personal marketing abilities.

Articles and backlinks. Next in order to SEO, this may be the most powerful portion of strategy for that rising internet business proprietor. In order to maneuver up within the search engine rank, you should have incoming hyperlinks (back links, as they?re called within the SEO globe). When the various search engines see an internet site with lots of natural backlinks, they start to see the website being an authority upon whatever subject the website is regarding. Thus, the site?s position begins to enhance. There tend to be many methods to go regarding getting back links, but among the best ways is actually through writing and submitting articles. There tend to be article ?farms? on the web, which web host your articles free of charge and after that sell all of them or present them to other site owners, who tend to be hungry with regard to content. This advantages you because at the conclusion of the content you?ll have included your own name along with a link aimed at your website. Every period someone holds your article to place on their own website, you obtain another essential link.

There really are a million successful techniques for making money online, but they are the three foundations. Go as well as research all of them, and your company would be the better for this.

lana peters lana peters jennifer nettles jennifer nettles giants vs saints suh suh

Food safety laboratory to be set up in India

IKA? - Global Leaders in Mixing Technology The IKA? Group is a global market leader for laboratory equipment, analytical and process technology. Magnetic stirrers, overhead stirrers, dispersers, shakers, mills, rotary evaporator, calorimeters, laboratory reactors and incubation shakers make up the laboratory and analytical equipment portfolio. Food Technology > Process & Production > Suppliers Spooner ? Bespoke Solutions in Proving, Baking, Toasting, Drying and Cooling Since 1932 Spooner Industries has provided pioneering technology and bespoke solutions in proving, baking, toasting, drying and cooling. For a diverse range of food products including bread, biscuits, cereals, pies, confectionary, pastry, pet foods, fast foods and ingredients. Food Technology > Process & Production > Suppliers COPA-DATA - Process Control and Line Management Systems COPA-DATA is the innovation leader in industrial automation software. With knowledge and experience gained from over 80,000 installed systems worldwide, COPA-DATA is setting standards and opening up new scope for efficient automation. Since 1987, we have been developing our HMI/SCADA technology zenon? at our headquarters in Salzburg, Austria. With this software we introduced the first graphic visualization system to run completely under Windows?. Food Technology > Process & Production > Suppliers NHP Electrical Engineering Products - Motor Control and Drives, Power Distribution and Automation Systems NHP Electrical Engineering Products Pty Ltd specialises in motor control and drives, power distribution and automation systems. Food Technology > Process & Production > Suppliers

orange bowl tim howard goal ben gibbard nfl playoff schedule tim howard scores nick cannon kidney failure consumer financial protection bureau

Clint Bowyer picks up 1st win of season at Sonoma

SONOMA, Calif. (AP) ? Clint Bowyer knew he could get to Victory Lane this season, his first with Michael Waltrip Racing.

He just didn't think it would be on a road course.

Bowyer picked up his first win with his new team Sunday by holding off Kurt Busch on the winding 1.99-mile road course at Sonoma. Although Bowyer finished fourth three previous times on this road course, his background is on dirt tracks and this style of racing isn't his strong suit.

So the irony of winning Sunday wasn't lost on Bowyer.

"To have this dirt boy from Kansas at Victory Lane on a road course is big, trust me," Bowyer said. "I saw Jeff Gordon, he's sitting there on the wall, he's won this race many times, he's a champion of this sport and I just beat him. I passed Jeff Gordon, and you have no idea, a young racer from Kansas, you don't forget stuff like that."

Bowyer dominated by leading 71 of the 112 laps. Defending race winner Busch, in an unsponsored car, was all over the bumper of Bowyer's Toyota late and got a final shot at taking the win away when caution flew with four laps remaining.

Only Busch damaged his car with roughly eight laps to go, and he worried the entire caution period whether his Chevrolet was ruined and had no chance of catching Bowyer through the two-lap overtime sprint to the finish.

Bowyer raced side-by-side with Busch at the green flag, then cleared Busch and pulled away for the win.

"Kurt raced me clean, he bumped me and roughed me up, but never did anything to jeopardize either one of us," Bowyer said.

Bowyer, who left Richard Childress Racing at the end of last season to join MWR, had to walk to Victory Lane to celebrate with his new crew after his car ran out of gas.

"I'm super excited for everybody involved," Bowyer said. "To switch teams like I did was a huge risk and a chance for me, and it was a chance to showcase my talents.

"I've had good teammates and good stuff before, but never like this. This is a young group, Michael stuck it out and I'm telling you, he's fixing to reap the benefits. He's worked hard."

It was a strong day all-around for MWR, which got a fourth-place finish from Brian Vickers, who was back to NASCAR after racing last weekend at Le Mans. Martin Truex Jr. led 15 laps, and was running in the top 10 until a late-race incident dropped him to 22nd.

"Everybody is just working together," Bowyer said. "That's something we are very proud of."

Tony Stewart passed Busch on the final lap to claim second, but said it was because Busch's car was struggling.

"Every time he would go in the corner, the rear end would shift, and it was running him to the outside of the track on entry and it was screwing his corner up," Stewart said. "Kind of got it by default there to a certain degree. Once we got by there, we just were not close enough in that last lap to get to Clint."

Busch wound up third. He was emotional after ? Busch missed Pocono earlier this month because he was suspended by NASCAR for verbally abusing a media member ? and said he was thrilled to compete for the win in an underfunded, unsponsored Phoenix Racing car.

"It's an amazing day, when you can do what we did," Busch said. "I'm a little choked up because A: We were in position. B: I was very considerate to Bowyer, who was going for his first win with the new team. And then C: which is most important, I made a mistake, I got into those tires in turn 11."

Busch, who has struggled with his temper on and off the track, saw a silver lining in his strong finish.

"If I can get my head on straight here, and after the race, then I could be able to race every weekend and go for victories," Busch said.

Vickers was fourth for MWR, followed by Hendrick Motorsports teammates Jimmie Johnson and Jeff Gordon.

Greg Biffle was seventh, followed by pole-sitter Marcos Ambrose, AJ Allmendinger and Joey Logano.

Most everyone believed the race would be a runaway win for either Ambrose or Gordon, but neither really contended.

Ambrose led the first 11 laps before plummeting through the field, and said the setup on his Richard Petty Motorsports Ford was just off.

"We really missed it," he said. "We missed it bad, and we did good to recover and get a top-10 out of it. We will take it and move on. We got the pole and had a lot of speed; we just missed it for the race.

"We were slow. It was just terrible. We had no speed in the car and we paid the price."

Gordon led one time for 13 laps before running out of gas as he was headed in for a scheduled pit stop.

There were only two cautions ? the fewest in track history for the Sprint Cup Series ? and so the race never shaped into the demolition derby most expected. Recent races on the 1.99-mile course had brought out road rage from drivers impatient to gain track position at a place with few passing zones.

It was never an issue on Sunday, though.

"I was happy about it," Stewart said. "Not having all of those cautions made it fun because you could actually race guys one-on-one a lot today versus, you know, having to worry about getting those big packs and big groups and having to worry about whether you're going to get run over or not."

Dale Earnhardt Jr., who ended his four-year losing streak last week at Michigan, failed to meet his goal of grabbing his first career top-10 at Sonoma. He was 15th on the final restart, but was stacked in traffic and spun, dropping him to 23rd.

"We had a good car, we've had better cars here, and we struggled all weekend," he said. "We hung around and were going to finish in the top-15, and on green-white-checkered, there are going to be some victims."

ghost rider spirit of vengeance hornets prince johan friso windows 8 logo anguilla gone with the wind michael jordan

Md. Teens Rebuild Vt. Homes Destroyed By Irene ? CBS Baltimore

WEST HARTFORD, Vt. (AP) ? A group of Maryland teenagers is helping rebuild two Vermont homes nearly destroyed last year by flooding from Tropical Storm Irene.

The group calls itself DreamBuilders, and the members came to the White River Junction area from churches and synagogues in the Baltimore area.

One of two homes they are helping to rebuild belongs to Linda and Randy Hart in West Hartford, across Route 14 from the White River.

When Irene struck, the family fled a birthday party for the Harts? grandson. When they returned, the house looked like a ruin.

?The muck and mud were everywhere, his presents were strewn all over, the outside toys were gone, the walls were missing,? Linda Hart said.

On Thursday, Linda Hart watched as new exterior walls rose from what was, on Monday, just a foundation. She told Vermont Public Radio the teenagers were making a dream out of what was once a nightmare.

?It?s been 10 months of being basically homeless, you know, begging off friends and family, so this is great,? she said.

John McBeth, an adult leader of DreamBuilders, said the teenagers gain as much as they give touring the country helping people rebuild after disasters.

?People have been honking their horns driving by all day,? he said. ?Someone wanted to bring us a pizza, but our meals are all set. The outpouring of love we are getting from this community is what makes it all worthwhile.?

DreamBuilders heard about the damage from Irene, and contacted COVER Home Repair, a White River Junction-based nonprofit agency. COVER?s director Rob Schultz said the volunteers brought not only labor, but money.

?And of course that?s the real stumbling block for so many of the Irene homeowners, is that in spite of everything they do not have the money to move forward,? said Schultz.

(Copyright 2012 by The Associated Press. All Rights Reserved.)

arizona immigration law aubrey huff the killers brandy steve nash julianne hough bruins